'Digital health' is the latest umbrella term to encompass technical innovation in the healthcare landscape. Digital health includes any technologies used to support diagnosis, prevention, treatment, adherence, lifestyle, and most importantly, patient engagement. The development of these solutions has been evolving for years, but their use in patient care and clinical research accelerated during the pandemic, particularly for cancer patients, who are highly vulnerable to COVID-19 morbidity and mortality. This white paper discusses individualized digital health, Digital Health in clinical trials, and how COVID-19 is accelerating the pace of oncology research.
Clinical trials face increasing pressure to deliver new treatments to market faster. IQVIA Connected Devices accelerates trial outcomes with medical device recommendations that fit your clinical study, deliver cleaner data, and speed data collection and analysis with lower patient and site burdens.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
.svg){kind=icon}
